Prognostic significance of PNI, SIRI and LIPI in non small-cell lung cancer

dc.contributor.authorOnur Yazdan BALÇIK
dc.contributor.authorAli AYTAÇ
dc.contributor.authorTugay AVCI
dc.contributor.authorBilgin DEMİR
dc.contributor.authorYusuf İLHAN
dc.contributor.authorGökhan KARAKYA
dc.contributor.authorAtike Pinar ERDOĞAN
dc.date.accessioned2024-07-24T09:14:56Z
dc.date.available2024-07-24T09:14:56Z
dc.date.issued2023
dc.description.abstractAim: Non-small cell lung cancer (NSCLC) is one of the 3 most common and deadly cancers. The aim of the current study is to investigate whether Prognostic Nutritional Index /PNI), Systemic Immune-Inflammation Index (SIRI), Lung Immune Prognostic Index (LIPI) has a prognostic significance in patients with metastatic NSLCL. Methods: Patients diagnosed with pathologically confirmed metastatic NSCLC in 5 different hospitals in Turkey between 2016-2022 were included in our study and analyzed retrospectively. overall survival (OS) and progression-free survival (PFS) were recorded. Results: The median PFS was 5.50 months, while the median OS was 16.03 months. Median OS was 14.86 months for the PNI-Low group and 17.2 months for the PNI-High group (p: <0.121). The median OS of the PNI-Low group was shorter than the PNI-High group, but there was no statistically significant difference between the groups. Median OS was 19.86 months for the SIRI-Low group and 14.23 months for the SIRI-High group (p: <0.112). Median OS was 17.76, 15.13, 13.73 months for the LIPI-Low, LIPI-intermediate group and LIPI-high group, there was no statistically significant difference between the groups (p: <0.391) Conclusion: In conclusion, PNI and SIRI may be significant in a prospective study in a specific patient group to be performed with a larger number of patients to predict the prognosis of patients with metastatic NSCLC.
dc.identifier.DOI-ID10.30565/medalanya.1314292
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/26486
dc.language.isoeng
dc.titlePrognostic significance of PNI, SIRI and LIPI in non small-cell lung cancer
dc.typeAraştırma Makalesi

Files